Aggressive Fibromatosis clinical trials at UC Health
1 in progress, 0 open to new patients
Sorry, not currently recruiting here
This study evaluates nirogacestat in the treatment of desmoid tumor/aggressive fibromatosis (DT/AF). Half of the participants will receive nirogacestat while the other half will receive placebo.